GRENKE AG (0R97)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 9.900 |
|---|---|
| 52-week range | 9.740 – 19.400 |
| Return, 1 month / 3 months | −9.8% / −14.4% |
| Return, 1 year / 3 years | −35.6% / −45.3% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 30.6% |
| Worst drawdown (1 year) | -36.6% |
| Average daily value traded | 0.07M EUR |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Grenke AG is a German financial services company based in Baden-Baden that specialises in small-ticket leasing. It helps small and medium-sized businesses acquire office equipment, information technology, machinery and other business assets through leasing arrangements, and it also offers factoring and banking services to commercial customers. Its clients are mainly tradespeople, retailers, professional practices and other small firms, largely in Europe, who want to use equipment without paying for it outright.
On this site GRENKE AG appears as a stock on the London Exchange (UK), code 0R97, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
GRENKE AG (0R97) trades on the London Exchange in UK. It last closed at EUR 9.900 on 23 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 3,069 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 35.6% and over the last three months it fell 14.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.2% | ||
| From 52-week high | -38.1% | ||
| Momentum | 17 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.4% | ||
| 6-month return | -22.6% | ||
| 12-month return, skipping the last month | -28.6% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.6% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.07M EUR | ||
| Zero-volume days | 10.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −4.3% |
|---|---|
| 1 month | −9.8% |
| 3 months | −14.4% |
| 6 months | −22.6% |
| 1 year | −35.6% |
| 3 years | −45.3% |
| 5 years | −66.0% |
Signals
| 50-day / 200-day average | 10.899 / 12.403 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.522 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Apr 2026 | EUR 0.4200 |
| 8 May 2025 | EUR 0.4000 |
| 2 May 2024 | EUR 0.4700 |
| 17 May 2023 | EUR 0.4500 |
| 26 May 2022 | EUR 0.5100 |
| 30 Jul 2021 | EUR 0.2600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.